首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Ribavirin/sofosbuvirLack of efficacy: 5 case reports
被引:0
作者
:
机构
:
来源
:
Reactions Weekly
|
2020年
/ 1833卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-020-87155-6
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:337 / 337
相关论文
共 50 条
[21]
AntineoplasticsLack of efficacy: 5 case reports
Reactions Weekly,
2023,
1943
(1)
: 90
-
90
[22]
ImmunosuppressantsLack of efficacy: 5 case reports
Reactions Weekly,
2023,
1944
(1)
: 309
-
309
[23]
CatequentinibLack of efficacy: 5 case reports
Reactions Weekly,
2023,
1939
(1)
: 131
-
131
[24]
VismodegibLack of efficacy: 5 case reports
Reactions Weekly,
2023,
1946
(1)
: 538
-
538
[25]
MethotrexateLack of efficacy: 5 case reports
Reactions Weekly,
2025,
2060
(1)
: 205
-
205
[26]
AtropineLack of efficacy: 5 case reports
Reactions Weekly,
2023,
1960
(1)
: 79
-
79
[27]
VismodegibLack of efficacy: 5 case reports
Reactions Weekly,
2022,
1920
(1)
: 454
-
454
[28]
AntineoplasticsLack of efficacy: 5 case reports
Reactions Weekly,
2023,
1948
(1)
: 56
-
56
[29]
NivolumabLack of efficacy: 5 case reports
Reactions Weekly,
2023,
1963
(1)
: 426
-
426
[30]
HydroxycarbamideLack of efficacy: 5 case reports
Reactions Weekly,
2021,
1853
(1)
: 228
-
228
←
1
2
3
4
5
→
共 50 条
[21]
AntineoplasticsLack of efficacy: 5 case reports
Reactions Weekly,
2023,
1943
(1)
: 90
-
90
[22]
ImmunosuppressantsLack of efficacy: 5 case reports
Reactions Weekly,
2023,
1944
(1)
: 309
-
309
[23]
CatequentinibLack of efficacy: 5 case reports
Reactions Weekly,
2023,
1939
(1)
: 131
-
131
[24]
VismodegibLack of efficacy: 5 case reports
Reactions Weekly,
2023,
1946
(1)
: 538
-
538
[25]
MethotrexateLack of efficacy: 5 case reports
Reactions Weekly,
2025,
2060
(1)
: 205
-
205
[26]
AtropineLack of efficacy: 5 case reports
Reactions Weekly,
2023,
1960
(1)
: 79
-
79
[27]
VismodegibLack of efficacy: 5 case reports
Reactions Weekly,
2022,
1920
(1)
: 454
-
454
[28]
AntineoplasticsLack of efficacy: 5 case reports
Reactions Weekly,
2023,
1948
(1)
: 56
-
56
[29]
NivolumabLack of efficacy: 5 case reports
Reactions Weekly,
2023,
1963
(1)
: 426
-
426
[30]
HydroxycarbamideLack of efficacy: 5 case reports
Reactions Weekly,
2021,
1853
(1)
: 228
-
228
←
1
2
3
4
5
→